[Alternative vasopressor agents in cardiopulmonary resuscitation].
Lindner
K H
KH
Universitätsklinik für Anästhesiologie, Universität Ulm.
D000804:Angiotensin II / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D000818:Animals; D016887:Cardiopulmonary Resuscitation / Q000379:methods*; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology; D004837:Epinephrine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D014662:Vasoconstrictor Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D014667:Vasopressins / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood
D014662:Vasoconstrictor Agents; D014667:Vasopressins; D000804:Angiotensin II; D004837:Epinephrine